SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-061641
Filing Date
2024-05-17
Accepted
2024-05-17 16:10:11
Documents
1
Period of Report
2023-06-30
Effectiveness Date
2024-05-17

Document Format Files

Seq Description Document Type Size
1 ARS ktra_ars_june_30_2023.pdf ARS 1086657
  Complete submission text file 0000950170-24-061641.txt   1498087
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: ARS | Act: 34 | File No.: 001-37823 | Film No.: 24959747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)